Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas

Cellular Physiology and Biochemistry

Volumn 33, Issue 1, 2014, Pages 173-184

  He, Qi Zhi ^a   Luo, Xun Zhen ^b   Wang, Kai ^a   Zhou, Qian ^a   Ao, Hong ^c   Yang, Yan ^a   Li, Shu Xia ^a   Li, Ying ^a   Zhu, Hui Ting ^a   Duan, Tony ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

High grade serous ovarian carcinoma; Non adherent spheres; Ovarian cancer stem cells; Self renewal; Tumorigenicity

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CA 125 ANTIGEN; CD133 ANTIGEN; CD24 ANTIGEN; CD44V ANTIGEN; CISPLATIN; CYTOKERATIN 7; OCTAMER TRANSCRIPTION FACTOR 4; PACLITAXEL; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TUMOR MARKER; BMI1 PROTEIN; HERMES ANTIGEN; NESTIN;

ABCG2 GENE; ADHERENT CELL; ADULT; ALDH1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; BMI 1 GENE; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENICITY; CD117 GENE; CD133 GENE; CD24 GENE; CD44 GENE; CELL CLONE; CELL DIFFERENTIATION; CELL ISOLATION; CELL RENEWAL; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYONIC STEM CELL; FEMALE; FLOW CYTOMETRY; GENE; GENE OVEREXPRESSION; HIGH GRADE SEROUS OVARIAN CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOG GENE; NESTIN GENE; NONHUMAN; OCT 4 GENE; OVARY CARCINOMA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOX 2 GENE; SPHERE FORMATION ASSAY; SPHEROID CELL; TUMOR XENOGRAFT; ANIMAL; CANCER GRADING; CARCINOGENESIS; CELL ADHESION; CELL SELF-RENEWAL; CELL SEPARATION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; MULTICELLULAR SPHEROID; NEOPLASM; OVARY TUMOR; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; SCID MOUSE; GENE EXPRESSION; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE;

ANIMALS; BIOMARKERS, TUMOR; CARCINOGENESIS; CELL ADHESION; CELL SELF RENEWAL; CELL SEPARATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; MICE, SCID; MIDDLE AGED; NEOPLASM GRADING; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PLURIPOTENT STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; SPHEROIDS, CELLULAR;

MUS;

EID: 84894526212     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356660     Document Type: Article

References (26)

1. Lengyel E: Ovarian cancer development and metastasis. Am J Pathol 2010;177:1053-1064.
2. Baccelli I, Trumpp A: The evolving concept of cancer and metastasis stem cells. J Cell Biol 2012;198:281-293.
3. Clevers H: The cancer stem cell: premises, promises and challenges. Nat Med 2011;17:313-319.
4. Kurman RJ, Shih I: Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011;42:918-931.
5. Kurman RJ, Shih I: The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 2010;34:433-443.
6. Vathipadiekal V, Saxena D, Mok SC, Hauschka PV, Ozbun L, Birrer MJ: Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer. PLoS One 2012;7:e29079.
7. Bapat SA, Mali AM, Koppikar CB, Kurrey NK: Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005;65:3025-3029.
8. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK: Ovarian cancer side population defines cells with stem celllike characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 2006;103:11154- 11159.
9. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP: Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008;68:4311-4320.
10. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506-5511.
11. Malpica A, Deavers MT, Lu K, Bodurka DC, Atkinson EN, Gershenson DM, Silva EG: Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol 2004;28:496-504.
12. McCluggage WG: Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology 2011;43:420-432.
13. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
14. Reynolds BA, Weiss S: Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992;255:1707-1710.
15. Tirino V, Desiderio V, Paino F, Papaccio G, De Rosa M: Methods for cancer stem cell detection and isolation. Methods Mol Biol 2012;879:513-529.
16. Clarke MF, Dick JE, Dirks PB, Eaves CJ, Jamieson CH, Jones DL, Visvader J, Weissman IL, Wahl GM: Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006;66:9339-9344.
17. Tirino V, Desiderio V, Paino F, De Rosa A, Papaccio F, La Noce M, Laino L, De Francesco F, Papaccio G: Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization. Faseb J 2013;27:13-24.
18. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, Marks JR, Berchuck A, Murphy SK: Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009;28:209-218.
19. Silva IA, Bai S, McLean K, Yang K, Griffith K, Thomas D, Ginestier C, Johnston C, Kueck A, Reynolds RK, Wicha MS, Buckanovich RJ: Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Res 2011;71:3991-4001.
20. Gao MQ, Choi YP, Kang S, Youn JH, Cho NH: CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells. Oncogene 2010;29:2672-2680.
21. Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A: Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 2003;113:643-655.
22. Chambers I: The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells. 2004, 6, 386-391.
23. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA: "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002;298:597-600.
24. Abubaker K, Latifi A, Luwor R, Nazaretian S, Zhu H, Quinn MA, Thompson EW, Findlay JK, Ahmed N: Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer 2013;12:24.
25. Lessard J, Sauvageau G: Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423:255-260.
26. Wang E, Bhattacharyya S, Szabolcs A, Rodriguez-Aguayo C, Jennings NB, Lopez-Berestein G, Mukherjee P, Sood AK, Bhattacharya R: Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer. PLoS One 2011;6:e17918.